Filing Details
- Accession Number:
- 0001645627-17-000069
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-26 12:07:07
- Reporting Period:
- 2017-05-23
- Filing Date:
- 2017-05-26
- Accepted Time:
- 2017-05-26 12:07:07
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1528172 | Endonovo Therapeutics Inc. | ENDV | Pharmaceutical Preparations (2834) | 452552528 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1645627 | Scott Michael Mann | 6320 Canoga Avenue Woodland Hills CA 91367 | President | No | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,929,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,930,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,931,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,932,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,933,224 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,934,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,935,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,936,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,937,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,938,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,939,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,940,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,941,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,942,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,943,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,944,429 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,945,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,946,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,947,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,948,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,949,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,950,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,951,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,952,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 410 | $0.06 | 20,952,659 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 590 | $0.06 | 20,953,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,954,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,955,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,956,249 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2017-05-23 | 1,000 | $0.06 | 20,957,249 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
